Karin Lindahl

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: LIVER INTERNATIONAL. 2024;44(1):228-240
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 years
Kamal H; Lindahl K; Ingre M; Gahrton C; Karkkonen K; Nowak P; Vesterbacka J; Stal P; Wedemeyer H; Duberg A-S; Aleman S
Article: JOURNAL OF INFECTIOUS DISEASES. 2021;224(3):407-414
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
Alkharaan H; Bayati S; Hellstrom C; Aleman S; Olsson A; Lindahl K; Bogdanovic G; Healy K; Tsilingaridis G; De Palma P; Hober S; Manberg A; Nilsson P; Pin E; Chen MS
Article: INFECTIOUS DISEASES. 2020;52(11):776-785
Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregnant women and their partners in Sweden
Millbourn C; Lybeck C; Einberg AP; Nordin M; Lindh G; Hokeberg I; Fredlund H; Fischler B; Fadl H; Duberg A-S; Lindahl K
Article: BMC INFECTIOUS DISEASES. 2019;19(1):955
Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County
Gahrton C; Westman G; Lindahl K; Oehrn F; Dalgard O; Lidman C; Nilsson L-H; Said K; Duberg A-S; Aleman S
Article: ACTA ONCOLOGICA. 2019;58(7):997-1002
Prevalence of chronic hepatitis C virus infection among childhood cancer survivors in Stockholm, Sweden
Einberg AP; Ekman A-T; Soderhall S; Millbourn C; Lindahl K; Harila-Saari A; Fischler B
Article: SEMINARS IN DIALYSIS. 2019;32(2):135-140
Direct acting anti-viral medications for hepatitis C: Clinical trials in patients with advanced chronic kidney disease
Bruchfeld A; Lindahl K
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2018;53(7):870-875
Prevalence and outcome of post-transfusion hepatitis C acquired at different ages and detected in look-back screening
Millbourn C; Einberg AP; Lindh G; Hokeberg I; Fischler B; Lindahl K
Article: JOURNAL OF HEPATOLOGY. 2018;68(5):904-911
Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis
Soderholm J; Millbourn C; Busch K; Kovamees J; Schvarcz R; Lindahl K; Bruchfeld A
Article: PLOS ONE. 2016;11(5):e0155142
Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection
Waldenstrom J; Westin J; Nystrom K; Christensen P; Dalgard O; Farkkila M; Lindahl K; Nilsson S; Norkrans G; Krarup H; Norrgren H; Buhl MR; Stenmark S; Lagging M
Article: THERAPEUTIC DRUG MONITORING. 2015;37(6):745-750
High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients
Lindahl K; Hornfeld E; Stahle L; Carlsson T; Weiland O; Parke A; Schvarcz R
Article: JOURNAL OF VIRAL HEPATITIS. 2008;15(9):641-645
Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin
Weiland O; Hollander A; Mattsson L; Glaumann H; Lindahl K; Schvarcz R; Lindh G; Enquist R; Quist A
Article: JOURNAL OF VIRAL HEPATITIS. 2006;13(5):316-321
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients
Bruchfeld A; Lindahl K; Reichard O; Carlsson T; Schvarcz R
Article: HEPATOLOGY. 2005;41(2):275-279
High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C
Lindahl K; Stahle L; Bruchfeld A; Schvarcz R
Article: JOURNAL OF VIRAL HEPATITIS. 2004;11(1):84-87
Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia
Lindahl K; Schvarcz R; Bruchfeld A; Ståhle L
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2003;18(8):1573-1580
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency
Bruchfeld A; Lindahl K; Ståhle L; Söderberg M; Schvarcz R
Article: THERAPEUTIC DRUG MONITORING. 2002;24(6):701-708
Dosage of ribavirin in patients with Hepatitis C should be based on renal function:: A population pharmacokinetic analysis
Bruchfeld A; Lindahl K; Schvarcz R; Ståhle L
Article: JOURNAL OF VIRAL HEPATITIS. 2000;7(6):409-413
HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin
Carlsson T; Lindahl K; Schvarcz R; Wejstal R; Uhnoo I; Shev S; Reichard O

Alla övriga publikationer

Corrigendum: JOURNAL OF INFECTIOUS DISEASES. 2023;227(4):603
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys (vol 224, pg 407, 2021)
Alkharaan H; Bayati S; Hellstrom C; Aleman S; Olsson A; Lindahl K; Bogdanovic G; Healy K; Tsilingaridis G; De Palma P; Hober S; Manberg A; Nilsson P; Pin E; Sallberg Chen M
Review: INFECTIOUS DISEASES. 2020;52(1):1-22
Management of hepatitis B virus infection, updated Swedish guidelines
Westin J; Aleman S; Castedal M; Duberg A-S; Eilard A; Fischlere B; Kampmann C; Lindahl K; Lindh M; Norkrans G; Stenmark S; Weiland O; Wejstal R
Meeting abstract: JOURNAL OF HEPATOLOGY. 2018;68:S367
Hepatitis C treatment in prisons through a nurse-led program with telemedicine
Olsson A; Roos K; Larsen S; Lindahl K; Gahrton C; Oksanen A; Ohrn F; Aleman S; Said K
Corrigendum: HEPATOLOGY. 2016;64(6):2278-2279
Poster Session II (Abstracts 730-1194) (vol 64, pg 361A, 2016)
Soderholm J; Millbourn C; Busch K; Kovamees J; Schvarcz R; Lindahl K; Bruchfeld A
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2012;44(7):502-521
Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations
Lagging M; Duberg A-S; Wejstal R; Weiland O; Lindh M; Aleman S; Josephson F
Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21(5):1444-1445
Pegylated interferon and ribavirin in haemodialysis patients
Bruchfeld A; Lindahl K; Reichard O; Carlsson T; Schvarcz R
Letter: JOURNAL OF HEPATOLOGY. 2006;44(2):432-433
Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia
Bruchfeld A; Lindahl K; Stahle L; Schvarcz R
Thesis / dissertation: 2005
Ribavirin : dose and concentration in treatment of chronic hepatitis C infected patients
Lindahl, Karin

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2023-2026

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Huddinge, Karolinska Institutet, 2005

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI